drug · small molecule
pociredir
Phase 2updated 3mo agoby $FULC Fulcrum Therapeutics, Inc.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 1, with 1 investigational indication.
indications
indications
Sickle Cell Disease
all catalysts(0)
nothing on the calendar yet
Trials studying pociredir
News(3)
- Aura, Schrödinger trim workforcesFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 2h ago
- Agios scraps sickle cell drugThe study failure costs Agios a chance to one-up Novo Nordisk and represents yet another setback in a disease that’s frustrated drugmakers of late.biopharma_dive · 21d ago
- Fulcrum exploring a potential sale after FDA sidelined its sickle cell drugFulcrum’s setback is the latest in a series of stumbles for the developers of sickle cell medicines, among them Pfizer, Novartis and Intellia Therapeutics.biopharma_dive · 2mo ago
Data sources
last refreshed 45m ago
Found something off?
comments(0)
5-min edit window · permanent after that